Navigation Links
Death from heart attack can be reduced by new drug combination

Heart attack remains one of the significant causes for mortality in more than 10 million people all over the world. It accounts for 29.2 percent of total global deaths according to the World Health Organization.// People who survive the episode require long-term care and support. Amongst the risk factors, the important ones are obesity, smoking, diabetes, high blood pressure and high cholesterol.

A majority of the deaths can now be prevented by a combination of aspirin and another drug Clopidogrel. The drug combination has been found to be very effective in preventing the clot formation in such patients.

Aspirin is a standard emergency treatment given to heart attack patients and the proposed drug (Clopidogrel) is the world's fourth biggest-selling drug. If the clopidogrel therapy was instituted to just 1 million people then more than 10000 deaths, non-fatal repeat heart attacks and stroke could be prevented.

The efficacy of the drug has been studied in a group of 45,800 patients against a placebo and patients who received 75 milligrams of the drug daily, in addition to an aspirin or other treatment for 4 weeks, had a 7 % and 14 % reduction in death rate and repeat heart attack rate respectively.

The researchers also found that using the blood pressure drug metoprolol intravenously and then orally as an emergency treatment for heart attacks reduced the relative risk of a repeat attack but raised the odds of cardiac shock, especially in the first day or so after being admitted to hospital.

The drug is complementary to aspirin but works in a different way. Only about two weeks of treatment with the drug would be needed so the costs would be small. The safety and the efficacy of the drug have also been satisfactory. Hence it has been suggested that the drug be used routinely on top of aspirin to produce a moderate yet significant health benefit in the emergency treatment of heart attack.


'"/>




Page: 1

Related medicine news :

1. White Cells Count Can Predict Heart Attack Death Risk
2. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
3. AIDS toll set to exceed Black Death
4. Fish Oil Fights Arrhythmias, Sudden Death
5. Painkiller Linked to Deaths
6. Death due to premature heartbeat after exercise
7. Preventing Childhood Deaths
8. Death Risk Higher in Obese Women with Colon Cancer
9. Death Among the Homeless
10. Diabetes on the Increase but Death Rate Falling
11. Drug Users and Risk of Death
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... , ... October 13, 2017 , ... ... serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing an ... to overcome a rare and deadly chromosome abnormality. , After struggling since birth ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of Eating ... excellence for the field of eating disorders, announces the opening of early registration ... Orlando, Florida at the Omni Resort at ChampionsGate. , The annual ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: